9 Directors’ Dealings

The Group engages in commercial relationships with its Management Board and the members of its Supervisory Board as related parties. In addition to cash compensation, the Company has issued stock options, convertible bonds, and performance shares to members of the Management Board.

The tables below show the shares, stock options, convertible bonds, and performance shares held by members of the Management Board and Supervisory Board, as well as any changes in their ownership in the first nine months of 2014.

Shares

  01/01/14  Additions  Forfeitures  Sales  09/30/14 
Management Board
Dr. Simon E. Moroney 452,885 0 0 0 452,885
Jens Holstein 6,500 0 0 4,500 2,000
Dr. Arndt Schottelius 2,000 33,000 0 33,000 2,000
Dr. Marlies Sproll 27,370 0 0 0 27,370
Total 488,755 33,000 0 37,500 484,255
 
Supervisory Board
Dr. Gerald Möller 9,000 0 0 0 9,000
Dr. Walter Blättler 2,019 0 0 0 2,019
Dr. Daniel Camus 0 0 0 0 0
Dr. Marc Cluzel 0 500 0 0 500
Karin Eastham 1,000 0 0 0 1,000
Dr. Geoffrey N. Vernon 0 0 0 0 0
Total 12,019 500 0 0 12,519

Stock Options

  01/01/14  Additions  Forfeitures  Exercises  09/30/14 
Management Board
Dr. Simon E. Moroney 0 0 0 0 0
Jens Holstein 0 0 0 0 0
Dr. Arndt Schottelius 0 0 0 0 0
Dr. Marlies Sproll 0 0 0 0 0
Total 0 0 0 0 0

Convertible Bonds

  01/01/14  Additions   Forfeitures   Exercises   09/30/14 
Management Board            
Dr. Simon E. Moroney 147,186 0 0 0 147,186
Jens Holstein 90,537 0 0 0 90,537
Dr. Arndt Schottelius 93,537 0 0 33,000 60,537
Dr. Marlies Sproll 93,537 0 0 0 93,537
Total 424,797 0 0 33,000 391,797

Performance Shares

  01/01/14  Additions   Forfeitures   Exercises   09/30/14 
Management Board            
Dr. Simon E. Moroney 48,676 5,979 0 0 54,655
Jens Holstein 33,339 4,095 0 0 37,434
Dr. Arndt Schottelius 33,339 4,095 0 0 37,434
Dr. Marlies Sproll 33,339 4,095 0 0 37,434
Total 148,693 18,264 0 0 166,957

The Supervisory Board of MorphoSys AG does not hold any stock options, convertible bonds, or performance shares.

Top